SCHEMBL29317112

SCHEMBL29317112

C1CN(CC2CCNCC2)CC2(C1)CCNCC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 12/20 0.50
ALDH1A1 P00352 8/20 0.48
CYP3A4 P08684 8/20 0.48
CYP2C19 P33261 6/20 0.48
TSHR P16473 7/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
CYP2C9 P11712 5/20 0.45
TP53 P04637 4/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
USP2 O75604 5/20 0.43
CYP1A2 P05177 5/20 0.42
HSD17B10 Q99714 4/20 0.42
HPGD P15428 1/20 0.39
MAPK1 P28482 1/20 0.39
CHRM5 P08912 1/20 0.37
ADRA2C P18825 1/20 0.37
ALOX15 P16050 1/20 0.37
GBA1 P04062 1/20 0.36
OPRM1 P35372 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL21073999 0.93 CYP2D6 (0.50) CYP2D6ALDH1A1CYP3A4CYP2C19TSHR
Hydrochloric Acid SCHEMBL31097575 0.86 CYP2D6 (0.45) CYP2D6ALDH1A1CYP3A4CYP2C19TSHR
SCHEMBL29977105 0.83 CYP2D6 (0.41) CYP2D6ALDH1A1CYP3A4CYP2C19TSHR
SCHEMBL25856127 0.83 CYP2D6 (0.47) CYP2D6ALDH1A1CYP3A4CYP2C19TSHR
SCHEMBL25924736 0.82 TSHR (0.57) CYP2D6ALDH1A1CYP3A4CYP2C19TSHR
SCHEMBL24717962 0.79 TSHR (0.45) CYP2D6ALDH1A1CYP3A4CYP2C19TSHR
SCHEMBL25026759 0.79 CYP2D6 (0.35) CYP2D6ALDH1A1CYP3A4CYP2C19TSHR
SCHEMBL29317316 0.78 CYP2D6 (0.38) CYP2D6ALDH1A1CYP3A4CYP2C19TSHR
SCHEMBL22564921 0.78 TSHR (0.44) CYP2D6ALDH1A1CYP3A4CYP2C19TSHR
SCHEMBL27162617 0.76 CYP2D6 (0.41) CYP2D6ALDH1A1CYP3A4CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4397661-A1 COMPOUND FOR DEGRADATION OF BCL-2 FAMILY PROTEINS AND MEDICAL APPLICATION THEREOF Xizang Haisco Pharmaceutical Co., Ltd. (CN) 2024-07-10 EP disclosed